Skip to content

Organon logo

Main menu
  • About us
    • Our products
      • Our focus
      • Products list
      • Patient support programs
      • Safety data sheets
      • Product patents
    • Our leaders
      • Leadership team
      • Executive team
      • Board of Directors
    • Business development
    • Our culture
    • Our stories
    • Policies & positions
  • ESG
    • Environmental, social & governance
    • Diversity, equity, inclusion & belonging
    • Suppliers
  • Media
    • Media
    • News
  • Investor relations
    • Investor relations overview
    • Events & presentations
    • SEC filings
    • Financial Information
    • Investor resources
  • Careers

Contact us

Global

Visit Organon's Twitter Visit Organon's Facebook Visit Organon's LinkedIn Visit Organon's Instagram Visit Organon's YouTube

Main menu
Organon site directory
  • The Americas
    • Organon
      Brazil
      Canada  English  ·  French
      Latin America
      Mexico
      USA
  • Europe
    • Organon
      Austria
      Belgium  Dutch  ·  English  ·  French
      Czech Republic
      Denmark
      Finland
      France
      Germany
      Ireland
      Italy
      Luxembourg  English  ·  French
      Netherlands  Dutch  ·  English
      Norway
      Portugal
      Russia
      Spain
      Sweden
      Switzerland
      United Kingdom
  • Asia Pacific
    • Organon
      Australia
      Hong Kong, China
      Indonesia
      Japan
      Malaysia
      New Zealand
      Philippines
      Singapore
      South Korea
      Taiwan
      Thailand
      Vietnam
  • Middle East & Africa
    • Organon
      Middle East  English  ·  Arabic
      Northwest Africa  French  ·  Arabic  ·  Turkey
      South Africa
View all locations and contact information
What can we help you find?
Search for:
Investors > Events & presentations > Events

Event Details

Organon & Co., Q4 2022 and Full Year Earnings Call

February 16, 2023 8:30 am ET

Icons / 16 / Microphone Created with Sketch. Webcast
Organon Q4 2022 Financial Results
Organon Q4 2022 Earnings Presentation
Transcript

Connect with us on social

Linkedin icon Twitter icon Facebook icon Instagram icon YouTube icon
Organon logo

Company

  • About us
  • Our leaders
  • Environmental, social & governance
  • Policies & positions

Resources

  • Patient resources
  • Investor relations
  • Media

Contact us

  • Contact information
  • Global locations
  • Forward-Looking Statement
  • Cookie policy
  • Privacy Policy
  • Terms of Use
  • Sitemap
© 2023 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies. This site is intended for residents of the United States.
Level Access website accessibility icon. TRUSTe

You are leaving Organon.com

Cancel Continue

Forward-looking statement of Organon

Any statements set forth on this website that are not historical facts are considered “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Organon’s management and are subject to significant risks and uncertainties. By their nature, forward-looking statements involve risks and uncertainties because they depend on circumstances that may or may not occur in the future. Although these statements are based on assumptions that we believe are reasonable when made, we caution you that forward-looking statements are not guarantees of future performance and you should not place undue reliance on them.

Organon undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s other filings with the Securities and Exchange Commission (SEC), including its registration statement on Form 10, available at the SEC’s Internet site (www.sec.gov).

Decline Accept